20 years of Cure Parkinson's
We’re here for the cure! This year marks 20 years since Cure Parkinson’s was founded by four people living with Parkinson’s who felt that nobody was taking a cure seriously enough and that there was an urgent need for a focused approach to curative research...
Learn more
Parkinson’s and pesticides
Much of our focus is on treatments, but treatments are only part of the story. A vital step for Cure Parkinson’s is to stop people from getting Parkinson’s in the first place. Read more about taking action against pesticide use.
GDNF – A new chapter
We welcome the news of further investment in GDNF (Glial Cell-Line Derived Neurotrophic Factor) by Parkinson’s UK.
Ambroxol – new real-world data
Ambroxol is a cough medication that Cure Parkinson’s is repurposing for potential use in treating Parkinson’s, and recently published data provides further support for this pioneering new study.
Cure Parkinson’s approves funding for new iron removing drug
Cure Parkinson’s continues to champion iron chelation for Parkinson’s. Trustees have now awarded a grant to develop the next generation of iron reducing drugs.
Webinar – Young Onset Parkinson’s
Presented by the Journal of Parkinson’s Disease, Cure Parkinson’s and Van Andel Institute. The latest instalment of our interactive webinar series, in partnership with The Journal of Parkinson’s Disease discusses recent publications around the theme of Young Onset Parkinson’s. The eminent panel, once again chaired…